Literature DB >> 15597543

TaqMan-based quantification of invasive cells in the chick embryo metastasis assay.

Edward Htun van der Horst1, Jörg H Leupold, Rainer Schubbert, Axel Ullrich, Heike Allgayer.   

Abstract

The chick embryonic metastasis (CEM) assay is a fast in vivo method to investigate the invasive properties of tumor cells. Until now, most quantification methods were semiquantitative and time-consuming. Here we describe a rapid quantification method using TaqMan technology to quantify the invaded tumor cells in the chorioallantoic membrane of fertilized eggs. This method is based on specific detection of human ALU sequences. Moreover, it provides high sensitivity over a wide linearity range.

Entities:  

Mesh:

Substances:

Year:  2004        PMID: 15597543     DOI: 10.2144/04376ST02

Source DB:  PubMed          Journal:  Biotechniques        ISSN: 0736-6205            Impact factor:   1.993


  22 in total

1.  The Chicken Egg Chorioallantoic Membrane (CAM) Model as an In Vivo Method for the Investigation of the Invasion and Metastasis Cascade of Malignant Tumor Cells.

Authors:  Jörg H Leupold; Nitin Patil; Heike Allgayer
Journal:  Methods Mol Biol       Date:  2021

2.  Therapeutic targeting of SPINK1-positive prostate cancer.

Authors:  Bushra Ateeq; Scott A Tomlins; Bharathi Laxman; Irfan A Asangani; Qi Cao; Xuhong Cao; Yong Li; Xiaoju Wang; Felix Y Feng; Kenneth J Pienta; Sooryanarayana Varambally; Arul M Chinnaiyan
Journal:  Sci Transl Med       Date:  2011-03-02       Impact factor: 17.956

3.  Metastatic properties and genomic amplification of the tyrosine kinase gene ACK1.

Authors:  Edward Htun van der Horst; Yan Y Degenhardt; Astrid Strelow; Anthony Slavin; Lawrence Chinn; Jessica Orf; Minqing Rong; Shyun Li; Lei-Hoon See; Ken Q C Nguyen; Timothy Hoey; Holger Wesche; Scott Powers
Journal:  Proc Natl Acad Sci U S A       Date:  2005-10-24       Impact factor: 11.205

4.  MicroRNAs-10a and -10b contribute to retinoic acid-induced differentiation of neuroblastoma cells and target the alternative splicing regulatory factor SFRS1 (SF2/ASF).

Authors:  Salvador Meseguer; Giridhar Mudduluru; Juan Manuel Escamilla; Heike Allgayer; Domingo Barettino
Journal:  J Biol Chem       Date:  2010-11-30       Impact factor: 5.157

5.  Role of transcriptional corepressor CtBP1 in prostate cancer progression.

Authors:  Rui Wang; Irfan A Asangani; Balabhadrapatruni V S K Chakravarthi; Bushra Ateeq; Robert J Lonigro; Qi Cao; Ram-Shankar Mani; Daniel F Camacho; Natalie McGregor; Taibriana E W Schumann; Xiaojun Jing; Radhika Menawat; Scott A Tomlins; Heng Zheng; Arie P Otte; Rohit Mehra; Javed Siddiqui; Saravana M Dhanasekaran; Mukesh K Nyati; Kenneth J Pienta; Nallasivam Palanisamy; Lakshmi P Kunju; Mark A Rubin; Arul M Chinnaiyan; Sooryanarayana Varambally
Journal:  Neoplasia       Date:  2012-10       Impact factor: 5.715

6.  The lncRNA PCAT29 inhibits oncogenic phenotypes in prostate cancer.

Authors:  Rohit Malik; Lalit Patel; John R Prensner; Yang Shi; Matthew K Iyer; Shruthi Subramaniyan; Alexander Carley; Yashar S Niknafs; Anirban Sahu; Sumin Han; Teng Ma; Meilan Liu; Irfan A Asangani; Xiaojun Jing; Xuhong Cao; Saravana M Dhanasekaran; Dan R Robinson; Felix Y Feng; Arul M Chinnaiyan
Journal:  Mol Cancer Res       Date:  2014-07-16       Impact factor: 5.852

7.  The Histone Methyltransferase EZH2 Mediates Tumor Progression on the Chick Chorioallantoic Membrane Assay, a Novel Model of Head and Neck Squamous Cell Carcinoma.

Authors:  Min Liu; Christina Springstead Scanlon; Rajat Banerjee; Nickole Russo; Ronald C Inglehart; Amanda L Willis; Stephen J Weiss; Nisha J D'Silva
Journal:  Transl Oncol       Date:  2013-06-01       Impact factor: 4.243

8.  The role of sarcosine metabolism in prostate cancer progression.

Authors:  Amjad P Khan; Thekkelnaycke M Rajendiran; Bushra Ateeq; Irfan A Asangani; Jyoti N Athanikar; Anastasia K Yocum; Rohit Mehra; Javed Siddiqui; Ganesh Palapattu; John T Wei; George Michailidis; Arun Sreekumar; Arul M Chinnaiyan
Journal:  Neoplasia       Date:  2013-05       Impact factor: 5.715

9.  The CAM Assay as an Alternative In Vivo Model for Drug Testing.

Authors:  Regine Schneider-Stock; Domenico Ribatti
Journal:  Handb Exp Pharmacol       Date:  2021

10.  Targeting the MIF/CXCR7/AKT Signaling Pathway in Castration-Resistant Prostate Cancer.

Authors:  Shahrzad Rafiei; Bin Gui; Jiaxin Wu; X Shirley Liu; Adam S Kibel; Li Jia
Journal:  Mol Cancer Res       Date:  2018-09-17       Impact factor: 5.852

View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.